Progress in fighting Alzheimer's disease highlighted at conference

Chen Xiaochun, a professor from the Chinese Medical Doctor Association, and Chen Shanwen, chairman of Hangzhou CellGer Biotechnology Co Ltd, introduce the implementation of a demonstration center for brain health screening to Chen Zhu, an academician at the Chinese Academy of Sciences. CHINA DAILY During the 2024 China Brain Health Conference held in Beijing on Saturday and Sunday, Hangzhou CellGer Biotechnology Co Ltd, an in vitro diagnostics company focusing on new immunodetection technologies and platforms, shared its insights and technologies on the prevention of Alzheimer's disease. As a progressive neurodegenerative disease, Alzheimer's disease is becoming an urgent brain health threat worldwide, and the next decade will be an important "window of opportunity" for China to address it, Chen Yang, general manager of Hangzhou CellGer Biotechnology, said during the event. The early screening, early intervention, and dynamic monitoring of Alzheimer's disease has proven effective in delaying its onset and therefore become essential in protecting the brain health of the people, Chen said. The company also introduced how the center develops during the China Brain Health Conference, while showcasing its new products including an Alzheimer's disease multiplex detection kit.